Schmertzler Michael

Schmertzler Michael is listed in filings as Director at PTC Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 6, 2026, including 7 public disclosures. Recent filings connect the profile to PTC Therapeutics, Inc. (PTCT) and Hamilton Lane Incorporated (HLNE). The current snapshot covers public activity from Feb 14, 2025 to Jan 6, 2026. Reported amounts are shown as $533.3K to $25. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.